Sponsor or institution
Clinical trials and research at Edi Therapeutics LLC
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $1.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
New IRAK4 inhibitor to fight inflammation-driven ovarian cancer spread and resistance
A new oral drug candidate called EDI-238382 targets a key inflammatory pathway to slow ovarian cancer growth, spread, and resistance to chemotherapy in a preclinical model.
-
Chimectin: a first-in-class jelly-like fibronectin treatment to heal xylazine-related skin wounds
A new topical therapy called Chimectin could speed up healing of painful skin wounds caused by xylazine, a contaminant in illicit opioids.
-
A new treatment for chronic wound healing using a fibronectin mimetic
This study is testing a new treatment called Chimectin to help heal stubborn wounds faster, especially for people with diabetes, by encouraging the body to repair itself better.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.